Since its introduction in 2002, TAVI has evolved dramatically and is now standard of care for
intermediate risk patients when the femoral approach can be implemented safely. The …

With a rapidly aging society, the number of patients with cardiovascular disease—in
particular aortic stenosis—is progressively increasing. Although conventional aortic valve …

Transcatheter aortic valve implantation (TAVI) is arguably the greatest advance in
interventional cardiology since the introduction of drug eluting stents in the 1990s. Results …

Severe symptomatic aortic valve stenosis (AS) is associated with high mortality and for
decades treatment was only feasible by cardiac surgery. Clinical outcomes and durability of …

Aortic sclerosis of different degrees of severity is found in about 26% of elderly subjects and
a diagnosis of severe aortic stenosis affects 2e4% of adults aged> 75 years. 1 The extent of …

Summary Background The French transcatheter aortic valve implantation (TAVI) registries,
linked with the nationwide administrative databases, have collected data on TAVI …

Key Points Although transfemoral transcatheter aortic valve replacement (TAVR) is the gold
standard, this approach is not be feasible in approximately 15% of the patients. Trans …

—Victor Hugo (1) Percutaneous replacement or repair of heart valves have been some of
the most exciting innovations in the field of interventional cardiology in the past decade …

Background Transcatheter aortic-valve implantation (TAVI) is a new therapeutic choice for
treating aortic stenosis in patients considered high risk for surgery. This blooming …

During the past decade TAVI has revolutionized the approach to heart valve disease. Its role
as a treatment modality for calcific degenerative aortic valve disease has been firmly …